APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biotechnology Contract Manufacturing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Biotechnology Contract Manufacturing Market Analysis and Forecast 2026-2032

2 May 2026246 pages

Choose your research edition.

Industry ResearchBiotechnology Contract Manufacturing Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Biotechnology Contract Manufacturing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Biotechnology Contract Manufacturing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biotechnology Contract Manufacturing Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Biotechnology Contract Manufacturing Market Analysis and Forecast 2026-2032246 pages · $4,950 USD

Market perspective

The global Biotechnology Contract Manufacturing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Biotechnology Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Biotechnology Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Biotechnology Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Biotechnology Contract Manufacturing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Biotechnology Contract Manufacturing include Lonza, Thermo Fisher Scientific, Inc., Catalent, Inc., Samsung Biologics, WuXi Biologics, Boehringer Ingelheim International GmbH, FUJIFILM Holding Corporation, AbbVie, Inc. and Eurofins Scientific, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Biotechnology Contract Manufacturing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biotechnology Contract Manufacturing, also provides the revenue of main regions and countries. Of the upcoming market potential for Biotechnology Contract Manufacturing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biotechnology Contract Manufacturing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biotechnology Contract Manufacturing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biotechnology Contract Manufacturing revenue, projected growth trends, production technology, application and end-user industry.

Biotechnology Contract Manufacturing Segment by Company

Lonza

Thermo Fisher Scientific, Inc.

Catalent, Inc.

Samsung Biologics

WuXi Biologics

Boehringer Ingelheim International GmbH

FUJIFILM Holding Corporation

AbbVie, Inc.

Eurofins Scientific

AGC, Inc.

Merck KgaA

Biotechnology Contract Manufacturing Segment by Type

Biologic Drug Substance Manufacturing

Biologic Drug Product Manufacturing

Biotechnology Contract Manufacturing Segment by Application

Monoclonal Antibodies

Cell Therapy & Gene Therapy

Antibody-Drug Conjugates (ADCs)

Vaccines

Therapeutic Peptides & Proteins

Others

Biotechnology Contract Manufacturing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biotechnology Contract Manufacturing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biotechnology Contract Manufacturing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biotechnology Contract Manufacturing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biotechnology Contract Manufacturing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biotechnology Contract Manufacturing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biotechnology Contract Manufacturing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biotechnology Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Biologic Drug Substance Manufacturing Major Player Table 3. Biologic Drug Product Manufacturing Major Player Table 4. Global Biotechnology Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Monoclonal Antibodies Major Player Table 6. Cell Therapy & Gene Therapy Major Player Table 7. Antibody-Drug Conjugates (ADCs) Major Player Table 8. Vaccines Major Player Table 9. Therapeutic Peptides & Proteins Major Player Table 10. Others Major Player Table 11. Biotechnology Contract Manufacturing Industry Trends Table 12. Biotechnology Contract Manufacturing Industry Drivers Table 13. Biotechnology Contract Manufacturing Industry Opportunities and Challenges Table 14. Biotechnology Contract Manufacturing Industry Restraints Table 15. Global Biotechnology Contract Manufacturing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Biotechnology Contract Manufacturing Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Biotechnology Contract Manufacturing Market Share by Region (2021-2026) Table 18. Global Biotechnology Contract Manufacturing Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Biotechnology Contract Manufacturing Market Share by Region (2027-2032) Table 20. Global Biotechnology Contract Manufacturing Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Biotechnology Contract Manufacturing Revenue Market Share by Players (2021-2026) Table 22. Global Biotechnology Contract Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Biotechnology Contract Manufacturing Key Players Headquarters & Area Served Table 24. Global Biotechnology Contract Manufacturing Players, Product Type & Application Table 25. Global Biotechnology Contract Manufacturing Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Biotechnology Contract Manufacturing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Biotechnology Contract Manufacturing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Biotechnology Contract Manufacturing Revenue Market Share by Type (2021-2026) Table 32. Global Biotechnology Contract Manufacturing Revenue Market Share by Type (2027-2032) Table 33. Global Biotechnology Contract Manufacturing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Biotechnology Contract Manufacturing Revenue Market Share by Application (2021-2026) Table 37. Global Biotechnology Contract Manufacturing Revenue Market Share by Application (2027-2032) Table 38. Lonza Company Information Table 39. Lonza Business Overview Table 40. Lonza Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Lonza Biotechnology Contract Manufacturing Product Portfolio Table 42. Lonza Recent Development Table 43. Thermo Fisher Scientific, Inc. Company Information Table 44. Thermo Fisher Scientific, Inc. Business Overview Table 45. Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 47. Thermo Fisher Scientific, Inc. Recent Development Table 48. Catalent, Inc. Company Information Table 49. Catalent, Inc. Business Overview Table 50. Catalent, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 52. Catalent, Inc. Recent Development Table 53. Samsung Biologics Company Information Table 54. Samsung Biologics Business Overview Table 55. Samsung Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio Table 57. Samsung Biologics Recent Development Table 58. WuXi Biologics Company Information Table 59. WuXi Biologics Business Overview Table 60. WuXi Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio Table 62. WuXi Biologics Recent Development Table 63. Boehringer Ingelheim International GmbH Company Information Table 64. Boehringer Ingelheim International GmbH Business Overview Table 65. Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio Table 67. Boehringer Ingelheim International GmbH Recent Development Table 68. FUJIFILM Holding Corporation Company Information Table 69. FUJIFILM Holding Corporation Business Overview Table 70. FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio Table 72. FUJIFILM Holding Corporation Recent Development Table 73. AbbVie, Inc. Company Information Table 74. AbbVie, Inc. Business Overview Table 75. AbbVie, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 77. AbbVie, Inc. Recent Development Table 78. Eurofins Scientific Company Information Table 79. Eurofins Scientific Business Overview Table 80. Eurofins Scientific Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio Table 82. Eurofins Scientific Recent Development Table 83. AGC, Inc. Company Information Table 84. AGC, Inc. Business Overview Table 85. AGC, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio Table 87. AGC, Inc. Recent Development Table 88. Merck KgaA Company Information Table 89. Merck KgaA Business Overview Table 90. Merck KgaA Biotechnology Contract Manufacturing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Merck KgaA Biotechnology Contract Manufacturing Product Portfolio Table 92. Merck KgaA Recent Development Table 93. North America Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. North America Biotechnology Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 99. North America Biotechnology Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 100. Europe Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 101. Europe Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 102. Europe Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 103. Europe Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 104. Europe Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. Europe Biotechnology Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 106. Europe Biotechnology Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 107. China Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 108. China Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 109. China Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 110. China Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 112. Asia Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 113. Asia Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 114. Asia Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 115. Asia Biotechnology Contract Manufacturing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 116. Asia Biotechnology Contract Manufacturing Revenue by Region (US$ Million) & (2021-2026) Table 117. Asia Biotechnology Contract Manufacturing Revenue by Region (US$ Million) & (2027-2032) Table 118. SAMEA Biotechnology Contract Manufacturing Revenue by Type (2021-2026) & (US$ Million) Table 119. SAMEA Biotechnology Contract Manufacturing Revenue by Type (2027-2032) & (US$ Million) Table 120. SAMEA Biotechnology Contract Manufacturing Revenue by Application (2021-2026) & (US$ Million) Table 121. SAMEA Biotechnology Contract Manufacturing Revenue by Application (2027-2032) & (US$ Million) Table 122. SAMEA Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. SAMEA Biotechnology Contract Manufacturing Revenue by Country (2021-2026) & (US$ Million) Table 124. SAMEA Biotechnology Contract Manufacturing Revenue by Country (US$ Million) & (2027-2032) Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Biotechnology Contract Manufacturing Image Figure 2. Global Biotechnology Contract Manufacturing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biotechnology Contract Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Biologic Drug Substance Manufacturing Image Figure 5. Biologic Drug Product Manufacturing Image Figure 6. Global Biotechnology Contract Manufacturing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biotechnology Contract Manufacturing Market Size Share 2021 VS 2025 VS 2032 Figure 8. Monoclonal Antibodies Image Figure 9. Cell Therapy & Gene Therapy Image Figure 10. Antibody-Drug Conjugates (ADCs) Image Figure 11. Vaccines Image Figure 12. Therapeutic Peptides & Proteins Image Figure 13. Others Image Figure 14. Global Biotechnology Contract Manufacturing Market Size (US$ Million) & (2021-2032) Figure 15. Global Biotechnology Contract Manufacturing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Biotechnology Contract Manufacturing Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Biotechnology Contract Manufacturing Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Biotechnology Contract Manufacturing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biotechnology Contract Manufacturing Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Biotechnology Contract Manufacturing Revenue Market Share by Type (2021-2032) Figure 22. Global Biotechnology Contract Manufacturing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Biotechnology Contract Manufacturing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Biotechnology Contract Manufacturing Revenue Market Share by Application (2021-2032) Figure 25. North America Biotechnology Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032) Figure 27. North America Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032) Figure 28. North America Biotechnology Contract Manufacturing Revenue Share by Country (2021-2032) Figure 29. United States Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Biotechnology Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032) Figure 34. Europe Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032) Figure 35. Europe Biotechnology Contract Manufacturing Revenue Share by Country (2021-2032) Figure 36. Germany Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Biotechnology Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032) Figure 46. China Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032) Figure 47. Asia Biotechnology Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032) Figure 49. Asia Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032) Figure 50. Asia Biotechnology Contract Manufacturing Revenue Share by Region (2021-2032) Figure 51. Japan Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Biotechnology Contract Manufacturing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032) Figure 59. SAMEA Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032) Figure 60. SAMEA Biotechnology Contract Manufacturing Revenue Share by Country (2021-2032) Figure 61. Brazil Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Biotechnology Contract Manufacturing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Biologic Drug Substance Manufacturing
  • Biologic Drug Product Manufacturing
Applications
  • Monoclonal Antibodies
  • Cell Therapy & Gene Therapy
  • Antibody-Drug Conjugates (ADCs)
  • Vaccines
  • Therapeutic Peptides & Proteins
  • Others
Companies covered
  • Lonza
  • Thermo Fisher Scientific, Inc.
  • Catalent, Inc.
  • Samsung Biologics
  • WuXi Biologics
  • Boehringer Ingelheim International GmbH
  • FUJIFILM Holding Corporation
  • AbbVie, Inc.
  • Eurofins Scientific
  • AGC, Inc.
  • Merck KgaA

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biotechnology Contract Manufacturing Market by Type
  3. 1.2.1 Global Biotechnology Contract Manufacturing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Biologic Drug Substance Manufacturing
  5. 1.2.3 Biologic Drug Product Manufacturing
  6. 1.3 Biotechnology Contract Manufacturing Market by Application
  7. 1.3.1 Global Biotechnology Contract Manufacturing Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Monoclonal Antibodies
  9. 1.3.3 Cell Therapy & Gene Therapy
  10. 1.3.4 Antibody-Drug Conjugates (ADCs)
  11. 1.3.5 Vaccines
  12. 1.3.6 Therapeutic Peptides & Proteins
  13. 1.3.7 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Biotechnology Contract Manufacturing Market Dynamics
  1. 2.1 Biotechnology Contract Manufacturing Industry Trends
  2. 2.2 Biotechnology Contract Manufacturing Industry Drivers
  3. 2.3 Biotechnology Contract Manufacturing Industry Opportunities and Challenges
  4. 2.4 Biotechnology Contract Manufacturing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biotechnology Contract Manufacturing Market Perspective (2021-2032)
  2. 3.2 Global Biotechnology Contract Manufacturing Growth Trends by Region
  3. 3.2.1 Global Biotechnology Contract Manufacturing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biotechnology Contract Manufacturing Market Size by Region (2021-2026)
  5. 3.2.3 Global Biotechnology Contract Manufacturing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biotechnology Contract Manufacturing Revenue by Players
  2. 4.1.1 Global Biotechnology Contract Manufacturing Revenue by Players (2021-2026)
  3. 4.1.2 Global Biotechnology Contract Manufacturing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biotechnology Contract Manufacturing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biotechnology Contract Manufacturing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biotechnology Contract Manufacturing Key Players Headquarters & Area Served
  7. 4.4 Global Biotechnology Contract Manufacturing Players, Product Type & Application
  8. 4.5 Global Biotechnology Contract Manufacturing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biotechnology Contract Manufacturing Market CR5 and HHI
  11. 4.6.3 2025 Biotechnology Contract Manufacturing Tier 1, Tier 2, and Tier 3
5 Biotechnology Contract Manufacturing Market Size by Type
  1. 5.1 Global Biotechnology Contract Manufacturing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 5.3 Global Biotechnology Contract Manufacturing Revenue Market Share by Type (2021-2032)
6 Biotechnology Contract Manufacturing Market Size by Application
  1. 6.1 Global Biotechnology Contract Manufacturing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  3. 6.3 Global Biotechnology Contract Manufacturing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Lonza
  2. 7.1.1 Lonza Company Information
  3. 7.1.2 Lonza Business Overview
  4. 7.1.3 Lonza Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Lonza Biotechnology Contract Manufacturing Product Portfolio
  6. 7.1.5 Lonza Recent Developments
  7. 7.2 Thermo Fisher Scientific, Inc.
  8. 7.2.1 Thermo Fisher Scientific, Inc. Company Information
  9. 7.2.2 Thermo Fisher Scientific, Inc. Business Overview
  10. 7.2.3 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Thermo Fisher Scientific, Inc. Biotechnology Contract Manufacturing Product Portfolio
  12. 7.2.5 Thermo Fisher Scientific, Inc. Recent Developments
  13. 7.3 Catalent, Inc.
  14. 7.3.1 Catalent, Inc. Company Information
  15. 7.3.2 Catalent, Inc. Business Overview
  16. 7.3.3 Catalent, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Catalent, Inc. Biotechnology Contract Manufacturing Product Portfolio
  18. 7.3.5 Catalent, Inc. Recent Developments
  19. 7.4 Samsung Biologics
  20. 7.4.1 Samsung Biologics Company Information
  21. 7.4.2 Samsung Biologics Business Overview
  22. 7.4.3 Samsung Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Samsung Biologics Biotechnology Contract Manufacturing Product Portfolio
  24. 7.4.5 Samsung Biologics Recent Developments
  25. 7.5 WuXi Biologics
  26. 7.5.1 WuXi Biologics Company Information
  27. 7.5.2 WuXi Biologics Business Overview
  28. 7.5.3 WuXi Biologics Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 WuXi Biologics Biotechnology Contract Manufacturing Product Portfolio
  30. 7.5.5 WuXi Biologics Recent Developments
  31. 7.6 Boehringer Ingelheim International GmbH
  32. 7.6.1 Boehringer Ingelheim International GmbH Company Information
  33. 7.6.2 Boehringer Ingelheim International GmbH Business Overview
  34. 7.6.3 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Boehringer Ingelheim International GmbH Biotechnology Contract Manufacturing Product Portfolio
  36. 7.6.5 Boehringer Ingelheim International GmbH Recent Developments
  37. 7.7 FUJIFILM Holding Corporation
  38. 7.7.1 FUJIFILM Holding Corporation Company Information
  39. 7.7.2 FUJIFILM Holding Corporation Business Overview
  40. 7.7.3 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 FUJIFILM Holding Corporation Biotechnology Contract Manufacturing Product Portfolio
  42. 7.7.5 FUJIFILM Holding Corporation Recent Developments
  43. 7.8 AbbVie, Inc.
  44. 7.8.1 AbbVie, Inc. Company Information
  45. 7.8.2 AbbVie, Inc. Business Overview
  46. 7.8.3 AbbVie, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AbbVie, Inc. Biotechnology Contract Manufacturing Product Portfolio
  48. 7.8.5 AbbVie, Inc. Recent Developments
  49. 7.9 Eurofins Scientific
  50. 7.9.1 Eurofins Scientific Company Information
  51. 7.9.2 Eurofins Scientific Business Overview
  52. 7.9.3 Eurofins Scientific Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Eurofins Scientific Biotechnology Contract Manufacturing Product Portfolio
  54. 7.9.5 Eurofins Scientific Recent Developments
  55. 7.10 AGC, Inc.
  56. 7.10.1 AGC, Inc. Company Information
  57. 7.10.2 AGC, Inc. Business Overview
  58. 7.10.3 AGC, Inc. Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 AGC, Inc. Biotechnology Contract Manufacturing Product Portfolio
  60. 7.10.5 AGC, Inc. Recent Developments
  61. 7.11 Merck KgaA
  62. 7.11.1 Merck KgaA Company Information
  63. 7.11.2 Merck KgaA Business Overview
  64. 7.11.3 Merck KgaA Biotechnology Contract Manufacturing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Merck KgaA Biotechnology Contract Manufacturing Product Portfolio
  66. 7.11.5 Merck KgaA Recent Developments
8 North America
  1. 8.1 North America Biotechnology Contract Manufacturing Revenue (2021-2032)
  2. 8.2 North America Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 8.2.1 North America Biotechnology Contract Manufacturing Revenue by Type (2021-2026)
  4. 8.2.2 North America Biotechnology Contract Manufacturing Revenue by Type (2027-2032)
  5. 8.3 North America Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 8.4 North America Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  7. 8.4.1 North America Biotechnology Contract Manufacturing Revenue by Application (2021-2026)
  8. 8.4.2 North America Biotechnology Contract Manufacturing Revenue by Application (2027-2032)
  9. 8.5 North America Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 8.6 North America Biotechnology Contract Manufacturing Revenue by Country
  11. 8.6.1 North America Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biotechnology Contract Manufacturing Revenue by Country (2021-2026)
  13. 8.6.3 North America Biotechnology Contract Manufacturing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biotechnology Contract Manufacturing Revenue (2021-2032)
  2. 9.2 Europe Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biotechnology Contract Manufacturing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biotechnology Contract Manufacturing Revenue by Type (2027-2032)
  5. 9.3 Europe Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biotechnology Contract Manufacturing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biotechnology Contract Manufacturing Revenue by Application (2027-2032)
  9. 9.5 Europe Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biotechnology Contract Manufacturing Revenue by Country
  11. 9.6.1 Europe Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biotechnology Contract Manufacturing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biotechnology Contract Manufacturing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biotechnology Contract Manufacturing Revenue (2021-2032)
  2. 10.2 China Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 10.2.1 China Biotechnology Contract Manufacturing Revenue by Type (2021-2026)
  4. 10.2.2 China Biotechnology Contract Manufacturing Revenue by Type (2027-2032)
  5. 10.3 China Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 10.4 China Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  7. 10.4.1 China Biotechnology Contract Manufacturing Revenue by Application (2021-2026)
  8. 10.4.2 China Biotechnology Contract Manufacturing Revenue by Application (2027-2032)
  9. 10.5 China Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biotechnology Contract Manufacturing Revenue (2021-2032)
  2. 11.2 Asia Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biotechnology Contract Manufacturing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biotechnology Contract Manufacturing Revenue by Type (2027-2032)
  5. 11.3 Asia Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biotechnology Contract Manufacturing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biotechnology Contract Manufacturing Revenue by Application (2027-2032)
  9. 11.5 Asia Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biotechnology Contract Manufacturing Revenue by Country
  11. 11.6.1 Asia Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biotechnology Contract Manufacturing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biotechnology Contract Manufacturing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biotechnology Contract Manufacturing Revenue (2021-2032)
  2. 12.2 SAMEA Biotechnology Contract Manufacturing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biotechnology Contract Manufacturing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biotechnology Contract Manufacturing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biotechnology Contract Manufacturing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biotechnology Contract Manufacturing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biotechnology Contract Manufacturing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biotechnology Contract Manufacturing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biotechnology Contract Manufacturing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biotechnology Contract Manufacturing Revenue by Country
  11. 12.6.1 SAMEA Biotechnology Contract Manufacturing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biotechnology Contract Manufacturing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biotechnology Contract Manufacturing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst